TRT and sexual function: what the evidence actually says

What did @kmartfit actually say?

The creator made three specific claims about testosterone replacement therapy and sex: that libido will "shoot through the roof" within weeks, that erections will be "harder and last longer," and that men will be able to "go multiple rounds in 24 hours" because optimized hormones speed recovery. He framed TRT as essentially a sexual performance upgrade for men with low testosterone, then funneled viewers toward a DM-based online TRT consultation.

These are not wild claims. They are, broadly speaking, the kinds of outcomes that show up in the clinical literature on hypogonadism treatment. But the framing is doing a lot of heavy lifting here. "A few weeks" and "shoot through the roof" are doing the work of turning a real but variable clinical effect into a personal guarantee.

Does the science back this up?

Partially, yes. The evidence for TRT improving libido and erectile function in men with confirmed low testosterone is reasonably solid. A 2016 New England Journal of Medicine paper, the Testosterone Trials (Snyder et al., NEJM 2016), found significant improvements in sexual desire and erectile function in hypogonadal men treated with testosterone gel compared to placebo. That is real data from a real trial.

The "multiple rounds in 24 hours" claim is where things get shakier. The refractory period is influenced by testosterone, yes, but it is also shaped by age, dopamine signaling, prolactin levels, and cardiovascular health. There is no clinical trial that says TRT specifically lets you have sex multiple times in a day. That claim is extrapolated well beyond what the studies actually show.

Libido improvement is typically the fastest-onset sexual benefit, sometimes appearing within 3 to 6 weeks, which is consistent with the creator's timeline. Erectile improvements tend to take longer, often 3 to 6 months (Buvat et al., Journal of Sexual Medicine, 2013).

What did they get wrong (or right)?

Credit where it is due: the core claim that TRT improves libido and erection quality in hypogonadal men is accurate and supported by multiple randomized controlled trials. The creator is not inventing these effects.

What he got wrong is the certainty and universality. TRT does not produce these results in every man, and it is not a fix for erectile dysfunction that has other causes, including cardiovascular disease, diabetes, or psychological factors. Wang et al. (Journal of Clinical Endocrinology and Metabolism, 2000) found that while libido improved consistently, erectile function improvements were more variable and depended on baseline hormone levels.

The "multiple rounds" framing is essentially unsubstantiated hype. It sounds like a testosterone product ad, not a description of clinical outcomes. Presenting it as a predictable benefit sets up expectations that will not hold for many men, particularly those over 45 or with comorbidities.

What should you actually know?

TRT is a legitimate medical treatment for confirmed hypogonadism, defined as low testosterone alongside actual symptoms. It is not a blanket sexual performance drug, and the sexual benefits are most pronounced in men who genuinely have low testosterone levels, not men who are in the low-normal range looking for an edge.

Before chasing these benefits, a proper workup matters. That means at least two morning total testosterone measurements, LH and FSH levels, and a conversation about what is actually causing symptoms. Erectile dysfunction in particular has a strong cardiovascular component. A 2017 meta-analysis (Corona et al., Journal of Sexual Medicine) found that TRT improved erectile function scores but that phosphodiesterase-5 inhibitors outperformed TRT alone in men with ED, and combination approaches sometimes worked better than either alone.

TRT also carries real risks that get no airtime in this video: erythrocytosis (elevated red blood cell count), suppression of natural testosterone production, fertility impacts, and potential cardiovascular effects that are still being studied. Any honest conversation about TRT benefits has to sit next to those considerations.